Filing Details
- Accession Number:
- 0001078274-21-000006
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-12-10 17:03:59
- Reporting Period:
- 2021-12-08
- Accepted Time:
- 2021-12-10 17:03:59
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
320017 | Caladrius Biosciences Inc. | CLBS | Services-Misc Health & Allied Services, Nec (8090) | 222343568 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1078274 | S Steven Myers | C/O Caladrius Biosciences, Inc. 110 Allen Road, 2Nd Floor Basking Ridge NJ 07920 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-12-08 | 33,785 | $0.89 | 146,839 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 8,434 | Indirect | By Steven S Myers IRA |
Common Stock | 1,954 | Indirect | By Steven S Myers Revocable Trust dated 12/1/2000 |
Common Stock | 802 | Indirect | By spouse |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.8802 to $0.9000, inclusive. The reporting person undertakes to provide Caladrius Biosciences, Inc., any security holder of Caladrius Biosciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
- Represents 37,735 unvested restricted stock awards granted under Issuer's 2018 Equity Incentive Compensation plan, which will vest on January 11, 2022.